The largest database of trusted experimental protocols

Omni kinetic software

Manufactured by GE Healthcare
Sourced in China

Omni-Kinetic software is a lab equipment product developed by GE Healthcare. It is designed to facilitate the analysis and interpretation of kinetic data collected from various laboratory experiments.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using omni kinetic software

1

Quantifying Tumor Perfusion Using DCE-MRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DCE-MRI data were analyzed using Omni-Kinetic software (version 1.0; GE Healthcare), with the dual-compartment pharmacokinetic model of Modified Tofts, as described previously (12 (link),19 (link)). Filice and Crisi (28 (link)) selected the superior sagittal sinus as their venous input function as it allowed for partial volume effects to be avoided on account of artery pulse; this was adopted in the present study and used as the venous input function. The Ktrans, backflux rate (kep), and fractional volume (ve) maps were generated using Omni-Kinetic software, and the highest permeability areas of the tumor entity and peritumor edema were selected as the ROI [tumor ROI area, between 5 and 10 mm2; peritumor edema determined around the tumor, 1–2 cm away from the margin of tumor entity (the boundary of strengthen region), with an area <10 mm2). Large vessels and necrosis were avoided in ROI placement. A total of 3 ROIs were selected and the mean value was calculated.
+ Open protocol
+ Expand
2

Automated DCE-MRI Prostate Lesion Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The T1 mapping and DCE-MRI data were transferred into the Omni-Kinetic software (GE Healthcare, China) to obtain the perfusion and permeability parameters of the lesions. The extended tofts linear model and the population arterial input function (AIF) embedded in the software were used for analysis, and the following quantitative parameters maps were obtained automatically: Ktrans, Kep, and Ve. For patients with positive DCE enhancement, a series of ROIs of lesions were manually delineated slice by slice using ITK-SNAP on the eighth dynamic contrast images. The eighth contrast images were chosen because that the lesions showed significantly enhancement while the entire prostate background was not enhanced at this stage. While for patients with negative DCE enhancement, it is necessary to refer to the T2WI and DWI/ADC sequence to locate the lesion on the enhancement images (Figure 2). The sketched ROIs were then matched to the pharmacokinetic maps.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!